These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 3909759)

  • 1. Antihypertensive, haemodynamic and metabolic effects of nifedipine slow-release tablets in elderly patients.
    Landmark K; Dale J
    Acta Med Scand; 1985; 218(4):389-96. PubMed ID: 3909759
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Determination of systemic haemodynamic alterations induced by slow-release nifedipine in elderly hypertensive patients using a non-invasive method: double-blind cross-sectional random study.
    Ferreira-Filho SR; Dorneles H
    J Hum Hypertens; 1995 Jul; 9(7):535-40. PubMed ID: 7562881
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antihypertensive and metabolic effects of long-term therapy with nifedipine slow-release tablets.
    Landmark K
    J Cardiovasc Pharmacol; 1985; 7(1):12-7. PubMed ID: 2580130
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nifedipine monotherapy in the hypertensive elderly: a placebo-controlled clinical trial.
    Schnapp P; Hermann H; Cernak P; Kahay J
    Curr Med Res Opin; 1987; 10(6):407-13. PubMed ID: 3552459
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Double-blind, placebo-controlled trial of twice-daily nifedipine as a step-2 agent in mild essential hypertension.
    Svetkey LP; Weinberger MH; Gavras H; Gavras I; Brown TS; Deterding J; Klotman PE
    J Clin Hypertens; 1987 Dec; 3(4):579-88. PubMed ID: 3330988
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Slow-release nifedipine as a single or additional agent in the treatment of essential hypertension--a placebo-controlled crossover study.
    Wing LM; Chalmers JP; West MJ; Bune AJ
    Clin Exp Hypertens A; 1985; 7(8):1173-85. PubMed ID: 4042390
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lisinopril versus slow release nifedipine in patients with essential hypertension: a multicentre study.
    Predel HG; Kramer HJ
    J Hum Hypertens; 1994 Oct; 8(10):777-80. PubMed ID: 7837215
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Double-blind, randomized comparative study of the antihypertensive effect of nicardipine slow-release and nifedipine slow-release in hypertensive patients with coronary heart disease.
    Maetzel FK; Teufel WE; Griebel A; Glocke MH
    Cardiovasc Drugs Ther; 1991 Jun; 5(3):647-54. PubMed ID: 1878335
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effects of slow-release nifedipine on hemodynamics and pharmacokinetics in elderly hypertensives].
    Shimamoto H; Shimamoto Y; Nakamura H
    Nihon Ronen Igakkai Zasshi; 1994 Dec; 31(12):943-9. PubMed ID: 7699942
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetic studies of nifedipine tablet. Correlation with antihypertensive effects.
    Taburet AM; Singlas E; Colin JN; Banzet O; Thibonnier M; Corvol P
    Hypertension; 1983; 5(4 Pt 2):II29-33. PubMed ID: 6345374
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Atenolol and sustained release nifedipine alone and in combination in hypertension. A randomised, double-blind, crossover study.
    Anderton JL; Vallance BD; Stanley NN; Crowe PF; Mittra B; Perks WH
    Drugs; 1988; 35 Suppl 4():22-6. PubMed ID: 3288467
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term antihypertensive and metabolic effects of nifedipine slow-release tablets in elderly hypertensives.
    Landmark K
    Acta Med Scand Suppl; 1986; 714():187-91. PubMed ID: 3472443
    [No Abstract]   [Full Text] [Related]  

  • 13. [Evaluation of the antihypertensive effect of capsule and tablet forms of nifedipine in moderate hypertension].
    Thibonnier M; Sassano P; Corvol P
    Arch Mal Coeur Vaiss; 1985 Nov; 78 Spec No():25-8. PubMed ID: 3937501
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antihypertensive efficacy of a slow release nifedipine tablet formulation given once daily in patients with mild to moderate hypertension. A placebo-controlled, double-blind parallel-group trial.
    Harder S; Rietbrock S; Thürmann P
    Arzneimittelforschung; 1994 Feb; 44(2):133-6. PubMed ID: 8147945
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antihypertensive effectiveness of nifedipine gastrointestinal therapeutic system in the elderly. The Modern Approach to the Treatment of Hypertension (MATH) Study Group.
    Bravo EL; Krakoff LR; Tuck ML; Friedman CP
    Am J Hypertens; 1990 Dec; 3(12 Pt 2):326S-332S. PubMed ID: 2078319
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety of the coadministration of carvedilol and nifedipine sustained-release in the treatment of essential hypertension.
    Juttmann JR; de Vries Robles P; Venuti RP
    J Cardiovasc Pharmacol; 1992; 19 Suppl 1():S134-7. PubMed ID: 1378141
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of slow release nifedipine tablets in patients with essential hypertension.
    Imai Y; Abe K; Munakata M; Sasaki S; Minami N; Sakuma H; Hashimoto J; Watanabe N; Sakuma M; Sekino H
    Arzneimittelforschung; 1992 Dec; 42(12):1434-8. PubMed ID: 1288507
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A double-blind, controlled, multicenter, randomized study comparing the antihypertensive effectiveness and tolerance of a daily dose of two nifedipine formulations: nifedipine microgranules versus nifedipine osmotic pump.
    de Roa ER; Botero R; Octavio JA; Berrizbeitia ML; Mayorca E; Castro P; Miranda R; Valecillo E; Aroca G; Aza G; González M
    Am J Ther; 2007; 14(2):140-6. PubMed ID: 17414581
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of nifedipine GITS and hydrochlorothiazide in the management of elderly patients with stage I-III diastolic hypertension.
    Dey HM; Soufer R; Hoffer P; Wackers FJ; Black HR
    Am J Hypertens; 1996 Jun; 9(6):598-606. PubMed ID: 8783785
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hemodynamic comparison of two nifedipine formulations in patients with essential hypertension.
    Frohlich ED; McLoughlin MJ; Losem CJ; Ketelhut R; Messerli FH
    Am J Cardiol; 1991 Nov; 68(13):1346-50. PubMed ID: 1951124
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.